RNA Market Cap & Key Metrics
Atrium Therapeutics, Inc.
$7.61
-$0.06(-0.78%)
15
Overall
--
Value
18
Tech
13
Quality
Market Cap
$130.17M
Volume
243.91K
52W Range
$7.54 - $16.77
Target Price
$25.00
RNA market cap is $130.17M. This page lists Atrium Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
RNA Key Metrics
- Market cap
- $130.17M
- EPS estimate, current year
- $-4.61
- EPS growth, 3-year
- -32.37%
- Quality score
- 13
- Technical score
- 18
| Fiscal year | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | $9.22M | $9.33M | $6.79M | $2.32M | $379.0K |
| EBITDA | -$172.61M | -$117.37M | -$43.77M | -$17.00M | -$10.12M |
| EPS | $-3.34 | $-2.85 | $-2.05 | $-1.44 | $-0.54 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNA | $7.61 | -0.8% | 243.91K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atrium Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW